岡山大学病院

Medicine & Life Sciences

1. Neoplasms 100%
2. Japan 89%
3. Non-Small Cell Lung Carcinoma 83%
4. Therapeutics 74%
5. Lung 55%
6. Drug Therapy 54%
7. Lung Neoplasms 53%
8. Survival 48%
9. Recurrence 44%
10. Neoplasm Metastasis 43%
11. Mutation 43%
12. Breast Neoplasms 42%
13. Kidney 39%
14. Tomography 39%
15. Tibial Meniscus 37%
16. Lung Transplantation 35%
17. Serum 33%
18. ErbB Receptors 33%
19. Cisplatin 33%
20. Genes 32%
21. Hepatocellular Carcinoma 31%
22. Bone and Bones 31%
23. Radiofrequency Ablation 31%
24. Retrospective Studies 29%
25. Confidence Intervals 27%
26. Transplants 27%
27. Safety 27%
28. Living Donors 26%
29. Prostatic Neoplasms 26%
30. Liver 26%
31. Stomach Neoplasms 26%
32. Cell Line 25%
33. Magnetic Resonance Imaging 25%
34. Small Cell Lung Carcinoma 25%
35. Liver Transplantation 24%
36. Biopsy 24%
37. Gefitinib 24%
38. Carcinoma 24%
39. Prospective Studies 23%
40. Multicenter Studies 22%
41. Incidence 22%
42. Cohort Studies 22%
43. Pediatrics 22%
44. Radiotherapy 20%
45. Adenoviridae 20%
46. Tooth 20%
47. Stomach 20%
48. Chemoradiotherapy 20%
49. Lymph Nodes 20%
50. Diabetic Nephropathies 19%
51. Odds Ratio 19%
52. Wounds and Injuries 19%
53. Tears 19%
54. Child 18%
55. Progression-Free Survival 18%
56. Proteins 18%
57. Hemorrhage 18%
58. Biomarkers 18%
59. Apoptosis 17%
60. Systematic Reviews 17%
61. Stents 17%
62. Squamous Cell Carcinoma 17%
63. Messenger RNA 17%
64. Colorectal Neoplasms 17%
65. Seizures 17%
66. Urinary Bladder Neoplasms 16%
67. Randomized Controlled Trials 16%
68. Atrial Heart Septal Defects 16%
69. Stroke 16%
70. Elderly 16%
71. Aneurysm 16%
72. Eye 16%
73. Pharmaceutical Preparations 16%
74. Docetaxel 15%
75. Tissue Donors 15%
76. Hematopoietic Stem Cell Transplantation 15%
77. Brain 15%
78. Protein-Tyrosine Kinases 15%
79. Esophageal Neoplasms 15%
80. Endoscopic Mucosal Resection 15%
81. Knee 15%
82. Survival Rate 15%
83. Renal Cell Carcinoma 15%
84. Observational Studies 15%
85. Thorax 15%
86. Pancreatic Neoplasms 15%
87. Cytokines 14%
88. Infections 14%
89. Growth 14%
90. Lymphoma 14%
91. Gene Expression 14%
92. Skin 14%
93. Meta-Analysis 14%
94. Inflammation 14%
95. Electroencephalography 14%
96. Adenocarcinoma of Lung 14%
97. In Vitro Techniques 14%
98. Antibodies 13%
99. Injections 13%
100. Pathologic Constriction 13%